Allergan Taytulla Softgel Capsules — Class I drug recall D-0875-2018
Terminated recall by Allergan, PLC., reported 2018-06-20, distributed nationwide. Contraceptive Tablets Out of Sequence.
| Recall number | D-0875-2018 |
|---|---|
| Product type | Drug |
| Classification | Class I |
| Status | Terminated |
| Voluntary or mandated | Voluntary |
| Recalling firm | Allergan, PLC., Madison, NJ, United States |
| Recall initiated | 2018-05-24 |
| Classified | 2018-06-15 |
| Reported by FDA | 2018-06-20 |
| Terminated | 2022-05-19 |
| Distributed | Nationwide (US) |
| UPC / GTIN / UDI-DI | 00300235862290 |
| NDC | 00023-5862, 00023-5862-28, 00023-5862-29, 00023-5862-30, 00023-5862-31 |
| Lot numbers | 05/19, 5620706 |
Product
Allergan Taytulla Softgel Capsules, 1 mg/20 mcg, 6x28 blister card Physicians's Sample - Not for Sale Distributed by: Allergan USA INC Irvine, CA 92612 NDC 0023-5862-28 (Blister Card) NDC 0023-5862-29 (Blister Carton) NDC 0023-5862-31 (Outer carton) UPC 300235862290
Reason for recall
Contraceptive Tablets Out of Sequence.
Machine access
This record, with every extracted code, the verbatim FDA record and provenance, is available from the recall API: GET https://api.data.aroqon.com/v1/recalls/D-0875-2018. Look up any UPC, UDI, NDC or lot with /v1/recalls/lookup?code=…. API docs · free and paid keys.
Source: U.S. Food and Drug Administration enforcement report via openFDA (CC0). Structured by Data Foundry (recall-structuring@2); last changed 2026-09-26. Not affiliated with or endorsed by FDA. Not medical or legal advice.